240 related articles for article (PubMed ID: 16904983)
1. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects.
Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB
Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.
Badgwell B; Lesinski GB; Magro C; Abood G; Skaf A; Carson W
J Surg Res; 2004 Jan; 116(1):129-36. PubMed ID: 14732359
[TBL] [Abstract][Full Text] [Related]
4. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
Chu CY; Lee SC; Liu SS; Lin YM; Shen PC; Yu C; Lee KH; Zhao X; Lee JW
Nucleic Acid Ther; 2011 Oct; 21(5):323-32. PubMed ID: 21916610
[TBL] [Abstract][Full Text] [Related]
5. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
6. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.
Mellor AL; Baban B; Chandler PR; Manlapat A; Kahler DJ; Munn DH
J Immunol; 2005 Nov; 175(9):5601-5. PubMed ID: 16237046
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells.
Domeika K; Magnusson M; Eloranta ML; Fuxler L; Alm GV; Fossum C
Vet Immunol Immunopathol; 2004 Sep; 101(1-2):87-102. PubMed ID: 15261695
[TBL] [Abstract][Full Text] [Related]
9. IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2.
Zimmerer JM; Lehman AM; Ruppert AS; Noble CW; Olencki T; Walker MJ; Kendra K; Carson WE
Clin Cancer Res; 2008 Mar; 14(5):1438-45. PubMed ID: 18316567
[TBL] [Abstract][Full Text] [Related]
10. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.
Lesinski GB; Anghelina M; Zimmerer J; Bakalakos T; Badgwell B; Parihar R; Hu Y; Becknell B; Abood G; Chaudhury AR; Magro C; Durbin J; Carson WE
J Clin Invest; 2003 Jul; 112(2):170-80. PubMed ID: 12865406
[TBL] [Abstract][Full Text] [Related]
11. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
Front Immunol; 2018; 9():783. PubMed ID: 29720976
[TBL] [Abstract][Full Text] [Related]
12. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
[TBL] [Abstract][Full Text] [Related]
13. IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanoma.
Lesinski GB; Badgwell B; Zimmerer J; Crespin T; Hu Y; Abood G; Carson WE
J Immunol; 2004 Jun; 172(12):7368-76. PubMed ID: 15187113
[TBL] [Abstract][Full Text] [Related]
14. CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.
Vollmer J; Jurk M; Samulowitz U; Lipford G; Forsbach A; Wüllner M; Tluk S; Hartmann H; Kritzler A; Müller C; Schetter C; Krieg AM
J Endotoxin Res; 2004; 10(6):431-8. PubMed ID: 15588427
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses.
Kitagaki K; Jain VV; Businga TR; Hussain I; Kline JN
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1260-9. PubMed ID: 12414759
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.
de Jong S; Chikh G; Sekirov L; Raney S; Semple S; Klimuk S; Yuan N; Hope M; Cullis P; Tam Y
Cancer Immunol Immunother; 2007 Aug; 56(8):1251-64. PubMed ID: 17242927
[TBL] [Abstract][Full Text] [Related]
17. Impact of immunomodulatory oligodeoxynucleotides on cytokine production in the lipopolysaccharide-stimulated human whole blood model.
Smith RL; Chong TW; Hughes MG; Hedrick TL; Evans HL; McElearney ST; Saalwachter AR; Raymond DP; Du K; Rudy CK; Pruett TL; Sawyer RG
Surgery; 2004 Aug; 136(2):464-72. PubMed ID: 15300216
[TBL] [Abstract][Full Text] [Related]
18. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
19. Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists.
Tu ATT; Hoshi K; Ikebukuro K; Hanagata N; Yamazaki T
Biomacromolecules; 2020 Sep; 21(9):3644-3657. PubMed ID: 32857497
[TBL] [Abstract][Full Text] [Related]
20. CpG oligodeoxynucleotides with double stem-loops show strong immunostimulatory activity.
Yang L; Wu X; Wan M; Yu Y; Yu Y; Wang L
Int Immunopharmacol; 2013 Jan; 15(1):89-96. PubMed ID: 23142503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
